A comparison of clinical outcomes between radiotherapy and autoimmune cells therapy in non-small cell lung cancer patients

Immunotherapy with DC vaccine and CIK cells might induce an immune response against NSCLC, improve QOL, and offer a survival benefit without severe toxicity in NSCLC patients, compared to radiotherapy.